Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Transplantation, 07/17/09
Schena FP et al. – At 2 years, SRL conversion among patients with baseline GFR more than 40 mL/min was associated with excellent patient and graft survival, no difference in BCAR, increased urinary protein excretion, and a lower incidence of malignancy compared with CNI continuation. Superior renal function was observed among patients who remained on SRL through 12 to 24 months.
Related Articles
Membranous nephropathy in children: clinical presentation and therapeutic approach
Pediatric Nephrology, 11/16/09
Relevance Score: 64%
Cutaneous Lupus Erythematosus: Issues in Diagnosis and Treatment
American Journal of Clinical Dermatology, 10/20/09
Relevance Score: 64%
Factors associated with response to calcineurin inhibitors in myasthenia gravis
Muscle & Nerve, 10/13/09
Relevance Score: 64%
Are calcineurin inhibitors still needed in early renal transplantation
Portuguese Journal of Nephrology and Hypertension, 10/12/09
Relevance Score: 64%
Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
Liver Transplantation, 10/01/09
Relevance Score: 64%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies
Urology, 12/07/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/07/09
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/07/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Public Attitudes Toward Kidney Donation By Friends and Altruistic Strangers in the United States
Transplantation, 12/07/09
Thymoglobulin Dose Optimization for Induction Therapy in High Risk Kidney Transplant Recipients
Transplantation, 12/07/09
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results
Clinical Transplantation, 12/07/09
Article Search
Sponsor


See Latest Articles


